SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHydrogenOne Regulatory News (HGEN)

  • There is currently no data for HGEN

Initiation from QuotedData

3 May 2023 17:19

RNS Number : 3288Y
HydrogenOne Capital Growth PLC
03 May 2023
 

HydrogenOne Capital Growth - Initiation from QuotedData

3rd May 2023

Funding a green revolution

HydrogenOne Capital Growth (HGEN) is the only pure play green (renewables-powered, no carbon dioxide produced) hydrogen fund available on the London listed market. It offers diverse exposure to nine exciting private hydrogen investments and a hydrogen production facility that is being developed in Germany.

Spurred on by the need to tackle climate change and improve energy security, globally, governments are devoting considerable resources to jump-starting the green hydrogen industry. HGEN is well-positioned to benefit as investee businesses scale rapidly over the coming years. The investment adviser has around £500m worth of additional opportunities available.

HGEN should be seen as a long-term investment. However, in the short-term, more risk-averse (some might say panicky) investors have driven a sharp, and we feel unwarranted, fall in HGEN's share price. With the shares at an 51.9% discount, new investors are being presented with an attractive entry point.

Full Research:

https://quoteddata.com/research/hydrogenone-capital-growth-funding-green-revolution-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on HydrogenOne Capital Growth Plc and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDULBGDGXX
Date   Source Headline
30th Jan 20237:00 amRNSNotice of quarterly portfolio, NAV and webinar
26th Jan 20237:00 amRNSInvestment in first green hydrogen project
17th Jan 20237:00 amRNSName Change of Administrator and Company Secretary
17th Jan 20237:00 amRNSNotice of Capital Markets Day
12th Jan 20237:00 amRNSChange of Adviser
15th Dec 20227:00 amRNS£1.1m investment in Strohm Holding B.V.
2nd Dec 20227:00 amRNSWebsite upgrade
16th Nov 20227:00 amRNSQ3 2022 Factsheet and NAV update
16th Nov 20227:00 amRNSSFDR Article 9 Fund and PRI signatory
15th Nov 20222:00 pmRNSNet Asset Value(s)
14th Nov 20222:00 pmRNSNet Asset Value(s)
11th Nov 20222:00 pmRNSNet Asset Value(s)
10th Nov 20222:00 pmRNSNet Asset Value(s)
9th Nov 20222:00 pmRNSNet Asset Value(s)
8th Nov 20222:00 pmRNSNet Asset Value(s)
7th Nov 20222:13 pmRNSNet Asset Value(s)
4th Nov 20222:00 pmRNSNet Asset Value(s)
3rd Nov 20222:00 pmRNSNet Asset Value(s)
3rd Nov 202211:50 amRNSHolding(s) in Company
3rd Nov 202211:50 amRNSChange of name of AIFM
3rd Nov 202211:09 amRNSCapital Markets Day Notification - Postponement
2nd Nov 20225:58 pmRNSHolding(s) in Company
2nd Nov 20225:35 pmRNSHolding(s) in Company
2nd Nov 20222:00 pmRNSNet Asset Value(s)
1st Nov 20222:00 pmRNSNet Asset Value(s)
31st Oct 20222:00 pmRNSNet Asset Value(s)
28th Oct 20222:00 pmRNSNet Asset Value(s)
27th Oct 20223:50 pmRNSNet Asset Value(s)
26th Oct 20222:24 pmRNSNet Asset Value(s)
25th Oct 20222:00 pmRNSNet Asset Value(s)
24th Oct 20222:34 pmRNSNet Asset Value(s)
21st Oct 20222:00 pmRNSNet Asset Value(s)
20th Oct 20222:00 pmRNSNet Asset Value(s)
19th Oct 20222:00 pmRNSNet Asset Value(s)
19th Oct 20221:17 pmRNSResult of Meeting
18th Oct 20222:00 pmRNSNet Asset Value(s)
17th Oct 20222:00 pmRNSNet Asset Value(s)
17th Oct 20222:00 pmRNSNet Asset Value(s)
17th Oct 202210:13 amRNSDirector Declaration
17th Oct 20227:00 amRNSCapital Markets Day
17th Oct 20227:00 amRNSCapital Markets Day
14th Oct 20222:00 pmRNSNet Asset Value(s)
13th Oct 20222:00 pmRNSNet Asset Value(s)
12th Oct 20222:00 pmRNSNet Asset Value(s)
11th Oct 20222:00 pmRNSNet Asset Value(s)
10th Oct 20221:00 pmRNSNet Asset Value(s)
7th Oct 20221:00 pmRNSNet Asset Value(s)
6th Oct 20221:31 pmRNSNet Asset Value(s)
5th Oct 20222:28 pmRNSNet Asset Value(s)
4th Oct 20222:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.